NCT04498611View on ClinicalTrials.gov

Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy

NACompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

August 15, 2021

Conditions
Carcinoma, Ductal, BreastInvasive Breast CancerIMAGE
Interventions
DIAGNOSTIC_TEST

contrast-enhanced breast MRI

Contrast-enhanced MRI will be performed on patients diagnosed with ductal carcinoma in-situ (DCIS) by preoperative biopsy.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04498611 - Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy | Biotech Hunter | Biotech Hunter